Zhencong Chen

1.8k total citations · 1 hit paper
52 papers, 1.1k citations indexed

About

Zhencong Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Zhencong Chen has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 28 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Zhencong Chen's work include Ferroptosis and cancer prognosis (18 papers), RNA modifications and cancer (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Zhencong Chen is often cited by papers focused on Ferroptosis and cancer prognosis (18 papers), RNA modifications and cancer (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Zhencong Chen collaborates with scholars based in China, United States and Taiwan. Zhencong Chen's co-authors include Cheng Zhan, Qun Wang, Jiaqi Liang, Yiwei Huang, Tao Lu, Mengnan Zhao, Zhengyang Hu, Guoshu Bi, Ming Li and Qihai Sui and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Zhencong Chen

47 papers receiving 1.1k citations

Hit Papers

Polyamine-mediated ferroptosis amplification acts as a ta... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer
    2024 69 citations Guoshu Bi, Jiaqi Liang et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhencong Chen China 21 685 465 455 371 184 52 1.1k
Guoshu Bi China 19 707 1.0× 493 1.1× 446 1.0× 301 0.8× 142 0.8× 66 1.1k
Yuanyong Wang China 20 762 1.1× 348 0.7× 573 1.3× 269 0.7× 121 0.7× 67 1.2k
Zhefang Wang Germany 11 535 0.8× 191 0.4× 422 0.9× 335 0.9× 149 0.8× 19 908
Simeng Wen China 17 559 0.8× 310 0.7× 407 0.9× 224 0.6× 73 0.4× 30 933
Yozo Suzuki Japan 15 652 1.0× 275 0.6× 255 0.6× 407 1.1× 175 1.0× 64 1.1k
Lixin Zheng China 14 655 1.0× 390 0.8× 333 0.7× 141 0.4× 140 0.8× 19 907
Satoshi Kiyama Japan 16 599 0.9× 199 0.4× 329 0.7× 324 0.9× 77 0.4× 36 1.0k
Li Xiong China 12 457 0.7× 684 1.5× 386 0.8× 194 0.5× 171 0.9× 32 1.1k
Yohei Sekino Japan 18 578 0.8× 330 0.7× 317 0.7× 207 0.6× 52 0.3× 88 916

Countries citing papers authored by Zhencong Chen

Since Specialization
Citations

This map shows the geographic impact of Zhencong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhencong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhencong Chen more than expected).

Fields of papers citing papers by Zhencong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhencong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhencong Chen. The network helps show where Zhencong Chen may publish in the future.

Co-authorship network of co-authors of Zhencong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhencong Chen. A scholar is included among the top collaborators of Zhencong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhencong Chen. Zhencong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bi, Guoshu, Jiaqi Liang, Yunyi Bian, et al.. (2024). Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer. Nature Communications. 15(1). 2461–2461. 69 indexed citations breakdown →
4.
Liang, Jiaqi, Guoshu Bi, Qihai Sui, et al.. (2024). Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma. Cell Reports. 43(2). 113771–113771. 20 indexed citations
5.
Bi, Guoshu, Jiaqi Liang, Guangyao Shan, et al.. (2023). Retinol Saturase Mediates Retinoid Metabolism to Impair a Ferroptosis Defense System in Cancer Cells. Cancer Research. 83(14). 2387–2404. 37 indexed citations
6.
Hu, Zhengyang, Xing Jin, Weifeng Hong, et al.. (2023). Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma. Cellular Oncology. 46(5). 1351–1368. 13 indexed citations
7.
Sui, Qihai, Zhengyang Hu, Jiaqi Liang, et al.. (2023). Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma. Cancer Letters. 581. 216497–216497. 14 indexed citations
8.
Liang, Jiaqi, Guangyin Zhao, Yunyi Bian, et al.. (2023). HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway. PeerJ. 11. e14996–e14996. 6 indexed citations
9.
Bi, Guoshu, Jiaqi Liang, Mengnan Zhao, et al.. (2022). miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways. Molecular Therapy — Nucleic Acids. 28. 366–386. 75 indexed citations
10.
Huang, Yiwei, Guangyao Shan, Jiaqi Liang, et al.. (2022). FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis. Cellular Oncology. 45(6). 1383–1399. 9 indexed citations
11.
Sui, Qihai, Jiaqi Liang, Zhengyang Hu, et al.. (2021). The clinical prognostic factors of patients with stage IB lung adenocarcinoma. Translational Cancer Research. 10(11). 4727–4738. 6 indexed citations
12.
Chen, Zhencong, Yiwei Huang, Zhengyang Hu, et al.. (2021). Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. Oncogenesis. 10(10). 71–71. 30 indexed citations
13.
Zheng, Yuansheng, Guoshu Bi, Yunyi Bian, et al.. (2021). The tumor environment immune phenotype of LUSC by genome-wide analysis. International Immunopharmacology. 96. 107564–107564. 6 indexed citations
14.
Bian, Yunyi, Guoshu Bi, Guangyu Yao, et al.. (2021). Integrative genome-scale analysis of immune infiltration in esophageal carcinoma. International Immunopharmacology. 93. 107371–107371. 6 indexed citations
15.
Chen, Zhencong, Mengnan Zhao, Ming Li, et al.. (2020). Identification of differentially expressed genes in lung adenocarcinoma cells using single-cell RNA sequencing not detected using traditional RNA sequencing and microarray. Laboratory Investigation. 100(10). 1318–1329. 23 indexed citations
16.
Xi, Junjie, Zhengyang Hu, Jiaqi Liang, et al.. (2020). Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I–IIIA non-small cell lung cancer: a propensity-matched analysis. Journal of Thoracic Disease. 12(6). 3043–3056. 8 indexed citations
17.
Lu, Tao, Xiaodong Yang, Yu Shi, et al.. (2020). Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules. Cell Discovery. 6(1). 69–69. 63 indexed citations
18.
19.
Zhao, Mengnan, Ming Li, Zhencong Chen, et al.. (2020). Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Immunogenetics. 72(9-10). 455–465. 25 indexed citations
20.
Liang, Jiaqi, Tao Lu, Zhencong Chen, Cheng Zhan, & Qun Wang. (2019). Mechanisms of resistance to pemetrexed in non-small cell lung cancer. Translational Lung Cancer Research. 8(6). 1107–1118. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoshu Bi Breakdown of academic impact, for papers by Yuanyong Wang Breakdown of academic impact, for papers by Zhefang Wang Breakdown of academic impact, for papers by Simeng Wen Breakdown of academic impact, for papers by Yozo Suzuki Breakdown of academic impact, for papers by Lixin Zheng Breakdown of academic impact, for papers by Satoshi Kiyama Breakdown of academic impact, for papers by Li Xiong Breakdown of academic impact, for papers by Yohei Sekino
Rankless by CCL
2026